. 2020 Jan 31;7(2):ofaa035. doi: 10.1093/ofid/ofaa035

Table 3.

Comparison of Clinical Responses Between IVCY and RTX Groups

	IVCY	RTX	P Value	95% CI
Median duration from immunosuppressive treatment initiation to clinical remission, d	84 (42–154)^a	99 (51–202)^a	.491	–95.63 to 49.13
Median duration of antimicrobial treatment used, d	415.5 (153–911)^a	203 (118–1040)^a	.432	–218.00 to 477.92
Median duration of remaining in clinical remission, d	613 (231–944)^a	334 (225–790)^a	.418	–274.35 to 588.35

Abbreviations: CI, confidence interval; IQR, interquartile range; IVCY, intravenous cyclophosphamide; RTX, rituximab.

^aMean (IQR).